Amal M. El-Gayar - Search Results

Year	Number of Results
2006	1
2007	1
2008	1
2013	3
2014	5
2015	1
2016	1
2017	4
2018	5
2019	2
2020	1
2021	2
2022	5
2023	0

1

Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats.

Elleithi YA, El-Gayar AM, Amin MN. Elleithi YA, et al. Among authors: el gayar am. Appl Biochem Biotechnol. 2022 Nov 11. doi: 10.1007/s12010-022-04203-0. Online ahead of print. Appl Biochem Biotechnol. 2022. PMID: 36367620

2

Sesamol Upregulates Death Receptors and Acts as a Chemosensitizer in Solid Ehrlich Carcinoma Model in Mice.

Abd Elrazik NA, El-Mesery M, El-Karef A, Eissa LA, El Gayar AM. Abd Elrazik NA, et al. Among authors: el gayar am. Nutr Cancer. 2022;74(1):250-264. doi: 10.1080/01635581.2020.1871496. Epub 2021 Jan 13. Nutr Cancer. 2022. PMID: 33439054

3

Selenium nanoparticles and quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement.

Mohamed AA, Zaghloul RA, Abdelghany AM, El Gayar AM. Mohamed AA, et al. Among authors: el gayar am. J Biochem Mol Toxicol. 2022 Apr;36(4):e22989. doi: 10.1002/jbt.22989. Epub 2022 Feb 18. J Biochem Mol Toxicol. 2022. PMID: 35179263

4

Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment.

Helmy SA, El-Mofty S, El Gayar AM, El-Sherbiny IM, El-Far YM. Helmy SA, et al. Among authors: el gayar am. Biomed Pharmacother. 2022 Jan;145:112376. doi: 10.1016/j.biopha.2021.112376. Epub 2021 Nov 5. Biomed Pharmacother. 2022. PMID: 34749055 Free article.

5

Effect of concomitant use of pitavastatin with neoadjuvant chemotherapy protocols in breast cancer patients: A randomized controlled clinical trial.

Dewidar SA, Hamdy O, Eltantawy A, El-Mesery M, El Gayar AM, Soliman MM. Dewidar SA, et al. Among authors: el gayar am. Saudi Pharm J. 2022 Oct;30(10):1486-1496. doi: 10.1016/j.jsps.2022.07.011. Epub 2022 Jul 25. Saudi Pharm J. 2022. PMID: 36387337 Free PMC article.

6

Nanoformulated natural therapeutics for management of streptozotocin-induced diabetes: potential use of curcumin nanoformulation.

El-Far YM, Zakaria MM, Gabr MM, El Gayar AM, Eissa LA, El-Sherbiny IM. El-Far YM, et al. Among authors: el gayar am. Nanomedicine (Lond). 2017 Jul;12(14):1689-1711. doi: 10.2217/nnm-2017-0106. Epub 2017 Jun 21. Nanomedicine (Lond). 2017. PMID: 28635562

7

Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.

Helmy SA, El-Mesery M, El-Karef A, Eissa LA, El Gayar AM. Helmy SA, et al. Among authors: el gayar am. Life Sci. 2019 Sep 15;233:116673. doi: 10.1016/j.lfs.2019.116673. Epub 2019 Jul 20. Life Sci. 2019. PMID: 31336121

8

Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma.

Hammouda NE, Salah El-Din MA, El-Shishtawy MM, El-Gayar AM. Hammouda NE, et al. Among authors: el gayar am. Sci Pharm. 2017 Mar 8;85(1):9. doi: 10.3390/scipharm85010009. Sci Pharm. 2017. PMID: 28282874 Free PMC article.

9

A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes.

El-Far YM, Zakaria MM, Gabr MM, El Gayar AM, El-Sherbiny IM, Eissa LA. El-Far YM, et al. Among authors: el gayar am. Nanomedicine (Lond). 2016 Oct;11(19):2581-602. doi: 10.2217/nnm-2016-0204. Epub 2016 Sep 13. Nanomedicine (Lond). 2016. PMID: 27623396

10

Arsenic trioxide and curcumin attenuate cisplatin-induced renal fibrosis in rats through targeting Hedgehog signaling.

Maghmomeh AO, El-Gayar AM, El-Karef A, Abdel-Rahman N. Maghmomeh AO, et al. Naunyn Schmiedebergs Arch Pharmacol. 2020 Mar;393(3):303-313. doi: 10.1007/s00210-019-01734-y. Epub 2019 Oct 14. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 31612257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results